Peter Chapman E. Cook
Président chez The CEO Circle Pty Ltd.
Profil
Peter Chapman E.
Cook is currently the Co-Chairman at The CEO Circle Pty Ltd., Director at Myostin Therapeutics Pty Ltd., Member at Australian Institute of Co. Directors, and Member at Royal Australian Chemical Institute, Inc. Previously, he served as the Chief Executive Officer & Managing Director at Orbital Corp.
Ltd., Chief Executive Officer at Faulding Pharmaceuticals Plc, Chairman at Simavita Ltd., Senior Independent Non-Executive Director at Quickstep Holdings Ltd., Director-Research & Development at Nicholas Kiwi Australasia Ltd., Deputy Managing Director at Invetech Pty Ltd., Director at Aviragen Therapeutics, Inc., and President-Protective Products Division at Ansell Ltd.
He also holds a graduate degree from RMIT University.
Postes actifs de Peter Chapman E. Cook
| Sociétés | Poste | Début |
|---|---|---|
| Royal Australian Chemical Institute, Inc. | Corporate Officer/Principal | 28/01/2011 |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | 28/01/2011 |
Myostin Therapeutics Pty Ltd.
 Myostin Therapeutics Pty Ltd. BiotechnologyHealth Technology Myostin Therapeutics Pty Ltd. is an Australian company that provides biotechnology research services. | Directeur/Membre du Conseil | - |
The CEO Circle Pty Ltd.
 The CEO Circle Pty Ltd. Miscellaneous Commercial ServicesCommercial Services The CEO Circle Pty Ltd. operates as a business group of CEOs and leaders of industry. It acts as an forum to share advice, exchange experiences and connect in an atmosphere of trust and mutual support with non-competing peers. The company was founded in 1994 and is headquartered in Mount Waverley, Australia. | Président | - |
Anciens postes connus de Peter Chapman E. Cook
| Sociétés | Poste | Fin |
|---|---|---|
| QUICKSTEP HOLDINGS LIMITED | Directeur/Membre du Conseil | 23/11/2017 |
| SIMAVITA LIMITED | Président | 12/09/2014 |
Aviragen Therapeutics, Inc.
 Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Directeur/Membre du Conseil | 10/09/2013 |
| Nicholas Kiwi Australasia Ltd. | Directeur Technique/Scientifique/R&D | - |
Invetech Pty Ltd.
 Invetech Pty Ltd. Industrial ConglomeratesProducer Manufacturing Invetech Pty Ltd. operates as an engineering consultancy firn. It specializes in product design, instrument development, and contract manufacturing in the healthcare markets. The firm's capabilities include fluidics, optics, motion, thermal control, consumable, industrial, experience and cartridge design, connectivity and systems integration, and quality systems. The company is headquartered in Melbourne, Australia. | Corporate Officer/Principal | - |
Formation de Peter Chapman E. Cook
| RMIT University | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| QUICKSTEP HOLDINGS LIMITED | Electronic Technology |
| ORBITAL CORPORATION LIMITED | Electronic Technology |
| ANSELL LIMITED | Producer Manufacturing |
| Entreprise privées | 10 |
|---|---|
Biota Holdings Pty Ltd.
 Biota Holdings Pty Ltd. Pharmaceuticals: MajorHealth Technology Biota Holdings Pty Ltd. operates as an anti infective drug development firm. The company was founded on October 2, 1985 and is headquartered in Notting Hil, Australia. | Health Technology |
| Royal Australian Chemical Institute, Inc. | |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
| Faulding Pharmaceuticals Plc | |
Invetech Pty Ltd.
Invetech Pty Ltd. Industrial ConglomeratesProducer Manufacturing Invetech Pty Ltd. operates as an engineering consultancy firn. It specializes in product design, instrument development, and contract manufacturing in the healthcare markets. The firm's capabilities include fluidics, optics, motion, thermal control, consumable, industrial, experience and cartridge design, connectivity and systems integration, and quality systems. The company is headquartered in Melbourne, Australia. | Producer Manufacturing |
| Nicholas Kiwi Australasia Ltd. | Health Technology |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Health Technology |
Simavita Ltd.
 Simavita Ltd. Information Technology ServicesTechnology Services Simavita Ltd. is a MedTec company. It is focused on the development of smart, wearable and disposable platform technologies for the health care market. The firm operates through the Australia and Rest of the World geographical segments. The company was founded on May 28, 1968 and is headquartered in North Sydney, Australia. | Technology Services |
Myostin Therapeutics Pty Ltd.
Myostin Therapeutics Pty Ltd. BiotechnologyHealth Technology Myostin Therapeutics Pty Ltd. is an Australian company that provides biotechnology research services. | Health Technology |
The CEO Circle Pty Ltd.
The CEO Circle Pty Ltd. Miscellaneous Commercial ServicesCommercial Services The CEO Circle Pty Ltd. operates as a business group of CEOs and leaders of industry. It acts as an forum to share advice, exchange experiences and connect in an atmosphere of trust and mutual support with non-competing peers. The company was founded in 1994 and is headquartered in Mount Waverley, Australia. | Commercial Services |
